Pfizer's stock is being considered in relation to potential changes in federal leadership, with some outlets discussing its potential as a desirable stock to own. However, the company is also facing competition and developments in the pharmaceutical industry, including a recent acquisition and an fda approval for a rival company. The impact of these factors on pfizer's stock is unclear.